🇺🇸 FDA
Pipeline program

A research study looking into the effect of NNC05190130 on blood levels of a birth control pill and emptying of the stomach in women after menopause

NN9541-4922

Phase 1 other active

Quick answer

A research study looking into the effect of NNC05190130 on blood levels of a birth control pill and emptying of the stomach in women after menopause for Healthy postmenopausal females (Type 2 Diabetes) is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Healthy postmenopausal females (Type 2 Diabetes)
Phase
Phase 1
Modality
other
Status
active

Clinical trials